Skip to content

Australia TGA approves tafasitamab combo in relapsed, refractory FL
Global trial gaps in representation complicate US drug approvals
Watch: Dr. Krish Patel on building partnerships between community and academic centers
NCI director says institute is ‘stable’ after turbulent year
Biosimilar filgrastim-laha (FILKRI) receives FDA approval

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Susan O’Brien, MD

Cellular Therapy

Susan O’Brien, MD

Leukemia

Susan O’Brien, MD

Lymphoma

Susan O’Brien, MD

Multiple Myeloma

Susan O’Brien, MD

Myelodysplastic Syndromes

Susan O’Brien, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

April 28, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Susan O’Brien, MD

Susan O’Brien, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
926 Views
2 years ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

FDA Green light

Lymphoma, Indolent B-Cell Lymphomas, News

Australia TGA approves tafasitamab combo in relapsed, refractory FL

April 27, 2026

May and June issue

Lymphoma, Aggressive B-Cell Lymphomas, News

Global trial gaps in representation complicate US drug approvals

April 24, 2026

Krish Patel

Community Oncology News, Trending now, Lymphoma, Aggressive B-Cell Lymphomas, Indolent B-Cell Lymphomas, Mantle Cell Lymphoma, T-Cell Lymphoma, Video Interviews

Watch: Dr. Krish Patel on building partnerships between community

April 22, 2026

Anthony_Letai_800x600

AACR 2026, Cellular Therapy, Leukemia, Acute Lymphoblastic Leukemia, Lymphoma, Aggressive B-Cell Lymphomas, Meetings / Conferences, Multiple Myeloma, Myelodysplastic Syndromes, News

NCI director says institute is ‘stable’ after turbulent year

April 21, 2026

FDA

Leukemia, Acute Myeloid Leukemia, News

Biosimilar filgrastim-laha (FILKRI) receives FDA approval

April 20, 2026

SOHO Israel banner

News

SOHO Israel postponed until November 19–20

April 20, 2026

Top Categories

Cellular Therapy

68

Leukemia

106

Lymphoma

117

Multiple Myeloma

91

Myelodysplastic Syndromes

36

Myeloproliferative Neoplasms

21

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Susan O’Brien, MD

Cellular Therapy

Susan O’Brien, MD

Leukemia

Susan O’Brien, MD

Lymphoma

Susan O’Brien, MD

Multiple Myeloma

Susan O’Brien, MD

Myelodysplastic Syndromes

Susan O’Brien, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

FDA Green light

Australia TGA approves tafasitamab combo in relapsed, refractory FL

May and June issue

Global trial gaps in representation complicate US drug approvals

Krish Patel

Watch: Dr. Krish Patel on building partnerships between community and academic centers

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.